RiDYMO® Designs Cyclic Peptide for "Undruggable" β-Catenin Target Within Two Months
BEIJING,Jan. 9,2025--In a recent achievement,DP Technology\'s hit discovery platformRiDYMO® has successfully designed a cyclic peptide targeting β-catenin,a historically "undruggable" p